Collplant Biotechnologies Reports 2024 Third Quarter Financial Results And Provides Corporate Update
Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and ...